A Study Evaluating Venetoclax Alone and in Combination With Azacitidine in Subjects With Relapsed/Refractory Myelodysplastic Syndromes (MDS)
Projektleiter:
Finanzierung:
Industrie;
This is a Phase 1b, open-label, multicenter study designed to evaluate the safety and pharmacokinetics of venetoclax as a single-agent and in combination with azacitidine in participants with relapsed/refractory Myelodysplastic Syndromes (MDS).
Kontakt
Prof. Dr. med. Haifa Kathrin Al-Ali
Martin-Luther-Universität Halle-Wittenberg
Universitätsklinik und Poliklinik für Innere Medizin IV
Ernst-Grube-Straße 40
06120
Halle (Saale)
Tel.:+49 345 5577002
weitere Projekte
Die Daten werden geladen ...